ZA200802587B - Anti-hypercholesterolemic compounds - Google Patents

Anti-hypercholesterolemic compounds

Info

Publication number
ZA200802587B
ZA200802587B ZA200802587A ZA200802587A ZA200802587B ZA 200802587 B ZA200802587 B ZA 200802587B ZA 200802587 A ZA200802587 A ZA 200802587A ZA 200802587 A ZA200802587 A ZA 200802587A ZA 200802587 B ZA200802587 B ZA 200802587B
Authority
ZA
South Africa
Prior art keywords
hypercholesterolemic compounds
hypercholesterolemic
compounds
Prior art date
Application number
ZA200802587A
Other languages
English (en)
Inventor
Robert J Devita
Gregori J Morriello
Lin Peter
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of ZA200802587B publication Critical patent/ZA200802587B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200802587A 2005-10-05 2008-03-20 Anti-hypercholesterolemic compounds ZA200802587B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72378105P 2005-10-05 2005-10-05

Publications (1)

Publication Number Publication Date
ZA200802587B true ZA200802587B (en) 2009-06-24

Family

ID=37845278

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200802587A ZA200802587B (en) 2005-10-05 2008-03-20 Anti-hypercholesterolemic compounds

Country Status (25)

Country Link
US (2) US20090137546A1 (fr)
EP (1) EP1934175B1 (fr)
JP (1) JP4879991B2 (fr)
KR (1) KR20080050610A (fr)
CN (1) CN101277930A (fr)
AR (1) AR058068A1 (fr)
AT (1) ATE488495T1 (fr)
AU (1) AU2006302584B2 (fr)
BR (1) BRPI0616834A2 (fr)
CA (1) CA2624481C (fr)
CR (1) CR9903A (fr)
DE (1) DE602006018341D1 (fr)
DO (1) DOP2006000211A (fr)
EA (1) EA200801008A1 (fr)
ES (1) ES2354460T3 (fr)
GT (1) GT200600444A (fr)
IL (1) IL190434A0 (fr)
MA (1) MA30006B1 (fr)
NO (1) NO20082075L (fr)
PE (1) PE20070493A1 (fr)
SV (1) SV2009002863A (fr)
TN (1) TNSN08153A1 (fr)
TW (1) TW200806623A (fr)
WO (1) WO2007044318A2 (fr)
ZA (1) ZA200802587B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7176193B2 (en) * 2002-06-19 2007-02-13 Sanofi-Aventis Deutschland Gmbh Acid-group-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
GB0215579D0 (en) * 2002-07-05 2002-08-14 Astrazeneca Ab Chemical compounds
GB0329778D0 (en) * 2003-12-23 2004-01-28 Astrazeneca Ab Chemical compounds
EP1699760B1 (fr) * 2003-12-23 2017-05-17 Merck Sharp & Dohme Corp. Composes anti-hypercholesterolemie
SA04250427A (ar) * 2003-12-23 2005-12-03 استرازينيكا ايه بي مشتقات ثاني فينيل أزيتيدون
UY29607A1 (es) * 2005-06-20 2007-01-31 Astrazeneca Ab Compuestos quimicos
AR057383A1 (es) * 2005-06-22 2007-12-05 Astrazeneca Ab Compuestos quimicos derivados de 2-azetidinona, formulacion farmaceutica y un proceso de preparacion del compuesto
SA06270191B1 (ar) * 2005-06-22 2010-03-29 استرازينيكا ايه بي مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
AR054482A1 (es) * 2005-06-22 2007-06-27 Astrazeneca Ab Derivados de azetidinona para el tratamiento de hiperlipidemias
MY148538A (en) * 2005-06-22 2013-04-30 Astrazeneca Ab Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
AR057380A1 (es) * 2005-06-22 2007-11-28 Astrazeneca Ab Compuestos quimicos derivados de 2-azetidinona y uso terapeutico de los mismos
TW200806623A (en) * 2005-10-05 2008-02-01 Merck & Co Inc Anti-hypercholesterolemic compounds
DE102005055726A1 (de) * 2005-11-23 2007-08-30 Sanofi-Aventis Deutschland Gmbh Hydroxy-substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
TW200811098A (en) * 2006-04-27 2008-03-01 Astrazeneca Ab Chemical compounds
JP2010513485A (ja) * 2006-12-20 2010-04-30 メルク・シャープ・エンド・ドーム・コーポレイション 抗高コレステロール血症化合物
DE102009023046B4 (de) 2008-05-30 2016-10-13 Hyundai Motor Company Automatisch schaltbares Getriebe eines Kraftfahrzeuges
WO2010056788A1 (fr) * 2008-11-17 2010-05-20 Merck Sharp & Dohme Corp. Composés anti-hypercholestérolémiques

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL102582A0 (en) * 1991-07-23 1993-01-14 Schering Corp Substituted beta-lactam compounds useful as hypocholesterolemic agents and processes for the preparation thereof
US5631365A (en) * 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
MX9606319A (es) * 1994-06-20 1997-05-31 Schering Corp Compuestos de acetidinonas sustituidas utiles como agentes hipocolesterolemicos.
US5624920A (en) * 1994-11-18 1997-04-29 Schering Corporation Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents
ATE349425T1 (de) * 2000-12-21 2007-01-15 Sanofi Aventis Deutschland Neue diphenzylazetidinone, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung zur behandlung von lipidstoffwechselstörungen
TWI291957B (en) * 2001-02-23 2008-01-01 Kotobuki Pharmaceutical Co Ltd Beta-lactam compounds, process for repoducing the same and serum cholesterol-lowering agents containing the same
US7176194B2 (en) * 2002-06-19 2007-02-13 Sanofi-Aventis Deutschland Gmbh Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
US7176193B2 (en) * 2002-06-19 2007-02-13 Sanofi-Aventis Deutschland Gmbh Acid-group-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
MXPA05009503A (es) * 2003-03-07 2005-10-18 Schering Corp Compuestos de azetidinona sustituidos, formulaciones y usos de los mismos para el tratamiento de hipercolesterolemia.
JP2005015434A (ja) * 2003-06-27 2005-01-20 Kotobuki Seiyaku Kk 血清コレステロール低下剤或はアテローム性硬化症の予防又は治療剤
EP1699760B1 (fr) * 2003-12-23 2017-05-17 Merck Sharp & Dohme Corp. Composes anti-hypercholesterolemie
EP1851197A2 (fr) * 2005-02-09 2007-11-07 Microbia, Inc. Derives de phenylazetidinone
WO2006138163A2 (fr) * 2005-06-15 2006-12-28 Merck & Co., Inc. Composes anti-hypercholesterolemiques
TW200806623A (en) * 2005-10-05 2008-02-01 Merck & Co Inc Anti-hypercholesterolemic compounds
DE102005055726A1 (de) * 2005-11-23 2007-08-30 Sanofi-Aventis Deutschland Gmbh Hydroxy-substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
CA2668094A1 (fr) * 2006-11-02 2008-05-08 Sanofi-Aventis Deutschland Gmbh Nouvelle diphenylazetidinone substituee par l'acide piperazin-1-sulfonique presentant des proprietes pharmacologiques ameliorees

Also Published As

Publication number Publication date
CN101277930A (zh) 2008-10-01
GT200600444A (es) 2007-05-04
CA2624481C (fr) 2012-04-03
US20090137546A1 (en) 2009-05-28
CR9903A (es) 2008-07-29
AU2006302584B2 (en) 2011-10-13
DE602006018341D1 (de) 2010-12-30
JP2009511475A (ja) 2009-03-19
DOP2006000211A (es) 2007-05-31
PE20070493A1 (es) 2007-06-13
US7704988B2 (en) 2010-04-27
ES2354460T3 (es) 2011-03-15
BRPI0616834A2 (pt) 2016-08-23
MA30006B1 (fr) 2008-12-01
EA200801008A1 (ru) 2009-02-27
JP4879991B2 (ja) 2012-02-22
ATE488495T1 (de) 2010-12-15
WO2007044318A3 (fr) 2007-07-12
IL190434A0 (en) 2008-11-03
SV2009002863A (es) 2009-02-19
NO20082075L (no) 2008-07-04
KR20080050610A (ko) 2008-06-09
EP1934175A2 (fr) 2008-06-25
TNSN08153A1 (en) 2009-10-30
TW200806623A (en) 2008-02-01
AR058068A1 (es) 2008-01-23
WO2007044318A2 (fr) 2007-04-19
US20070078098A1 (en) 2007-04-05
CA2624481A1 (fr) 2007-04-19
EP1934175B1 (fr) 2010-11-17
AU2006302584A1 (en) 2007-04-19

Similar Documents

Publication Publication Date Title
EP1893222A4 (fr) Composes anti-hypercholesterolemiques
IL190434A0 (en) Anti-hypercholesterolemic compounds
GB0503962D0 (en) Compounds
GB0507602D0 (en) Compounds
GB0502418D0 (en) Compounds
GB0502316D0 (en) Compounds
EP1961741A4 (fr) COMPOSES m-CARBAZOLYLPHENYLE
GB0502310D0 (en) Compounds
GB0502299D0 (en) Compounds
GB0503961D0 (en) Compounds
IL186752A0 (en) Motilide compounds
GB0505084D0 (en) Compounds
EP2124549A4 (fr) Composé anti-hypercholestérolémique
EP1907385A4 (fr) Composes
GB0506467D0 (en) Compounds
GB0505086D0 (en) Compounds
GB0505509D0 (en) Compounds
GB0505735D0 (en) Compounds
GB0501985D0 (en) Compounds
EP1867650A4 (fr) Composes de l hydroxymethylbore
GB0505085D0 (en) Compounds
GB0501984D0 (en) Compounds
GB0503145D0 (en) Compounds
GB0501838D0 (en) Compounds
GB0507597D0 (en) Compounds